Download Emerging Medical Technologies Spotlight: A Report of Investment &

Brochure
More information from http://www.researchandmarkets.com/reports/2213981/
Emerging Medical Technologies Spotlight: A Report of Investment &
Partnering Opportunities 2012 – Edition 7
Description:
This report includes details on 30 emerging medical technology companies that have been identified by LSI's
in-house research team in July 2012.
All companies include technology, market(s), key executive, and contact information.
Coverage includes innovations in a broad spectrum of medical technology areas including:
- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Companies
- Drug Delivery Companies
- Endocrine Companies
- Gastroenterology Companies
- Gynecology/Women's Health Companies
- Imaging Companies
- Neurology Companies
- Oncology Companies
- Ophthalmology Companies
- Orthopedics Companies
- Pain Management Companies
- Patient Management/Monitoring Companies
- Pharmaceutical Companies
- Respiratory Companies
- Spine Companies
- Surgery Companies
- Urology Companies
- Vascular Companies
- Wound Management Companies
This report may be purchased separately or as part of LSI's Emerging Medical Technologies Spotlight Library.
Contents:
BRIEF TECHNOLOGY DESCRIPTIONS FOR COMPANIES COVERED
- Fatty acid synthase (FASN) inhibitors with pharmaceutical properties that overcome the shortcomings of
earlier generations of inhibitors, for the treatment of chronic hepatitis C virus (HCV) and pancreatic,
prostatic, breast, and colorectal tumors
- A custom fit, rehabilitative body suit that offers instantaneous back pain relief, trains and conditions the
body to prevent or rehabilitate from back injuries, and increases the overall long-term health of the spine
- Biomaterial and regenerative medicine products for ophthalmological applications: ologen(R) Collagen
Matrix, BioCornea, and Biolens
- First-in-class, small molecule compounds that successfully manage and treat chronic pain, by inhibiting
P2X3 receptors
- Biomaterials for post-surgical adhesion prevention, scar prevention, wound care, and tissue reconstruction
- Micro-catheter platform that uses a proprietary microfluidic design for the delivery of drug/active
molecules directly to the central nervous system for the treatment of difficult/chronic neurological
conditions
- Protein therapeutics with extremely high target binding specificity for the treatment of cancer and immune
-mediated diseases
- An antibody that blocks the calcitonin gene-related peptide (CGRP) pathway to prevent migraine headaches
- Drugs for the treatment of depression, anxiety, epilepsy, pain, glaucoma, spasticity, and a variety of other
CNS-related conditions
- Nanopharmaceuticals optimized to make drugs more effective and with fewer side effects
- Ocular microinjection platform for non-surgical, targeted delivery of drugs and proteins into the
suprachoroidal space
- Biology and chemistry platforms for the development of small molecule drugs to stop Alzheimer's disease
and other CNS-related conditions
- New generation of fully recombinant, protease-activated monoclonal antibodies that can achieve
unprecedented levels of tissue-specific targeting
- A recombinant protein to treat X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disorder
that can be life-threatening
- Minimally invasive, image-guided breast biopsy and tissue removal technologies
- Products that support transcatheter interventions for the heart
- Non-invasive series of genetic tests, designed to offer valuable insights into the biology of patients with
mood disorders and to support the development of personalized medicine
- New avenue of nucleotide therapeutic drug discovery via modulation of cellular miRNA to treat a wide
range of diseases, including cancer, fibrosis, inflammation, and infectious and degenerative diseases
- Diagnostic tests for the early identification of newborns suffering from critical oxygen supply deficit during
birth (Asphyxia), a major cause for brain injury, often followed by life-long disability
- A device that enables surgeons to check for remaining cancer cells at the tumor site, immediately following
surgical removal of the tumor
- The first vaccine to demonstrate efficacy in reducing the mortality of otherwise highly lethal bloodstream
infections due to either Candida or S. aureus (including MRSA)
- Drugs to improve health for patients by modulating disease-associated long non-coding RNA (lncRNA),
thereby restoring normal expression of individual targeted genes
- Neuromonitoring devices to prevent nerve damage in all types of surgical procedures
- Novel technology for the treatment of acne
- Fully synthetic and targeted vaccines that induce an antigen-specific immune activation or an antigenspecific immune tolerance for therapeutic and prophylactic applications
- Technology that will allow hospitals to consolidate the multiple types of infusion pumps used throughout
their organization into a single type of device
- A laser procedure that removes the brown pigment (melanin) from the top layer of the iris, in order to
change human eye color (to blue) permanently
- Decision support software, integrated with vital sign monitoring equipment in hospital ICUs/EDs, to provide
novel insights into a patient's current status and future trajectory
- Revolutionary topical antifungal with: exceptional potency, the ability to penetrate the nail, a dual mode of
action, and exemplary safety profile
- Unique diagnostic and monitoring technologies: 1-"Smart Optic Capillaroscope" for non-invasive
diagnostics of early disorders in the smallest vessels-capillaries; 2-"Hemodynamic Lab" for simultaneous
diagnostics of the whole vascular system; and 3-"Meteolaboratory with Feedback Effect" for controlling
influence of meteorological factors on the human organism
Ordering:
Order Online - http://www.researchandmarkets.com/reports/2213981/
Order by Fax - using the form below
Order by Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from
USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit
http://www.researchandmarkets.com/contact/
Order Information
Please verify that the product information is correct and select the format(s) you require.
Product Name:
Emerging Medical Technologies Spotlight: A Report of Investment & Partnering
Opportunities 2012 – Edition 7
Web Address:
http://www.researchandmarkets.com/reports/2213981/
Office Code:
SCHL3FA7
Product Formats
Please select the product formats and quantity you require:
Quantity
Electronic (PDF) Single User:
USD 395
Electronic (PDF) Enterprisewide:
USD 1975
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title:
First Name:
Mr
Mrs
Dr
Miss
Last Name:
Email Address: *
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
* Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Ms
Prof
Page 2 of 2
Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by credit card:
You will receive an email with a link to a secure webpage to enter your
credit card details.
Pay by check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Center,
Taylors Lane,
Dublin 8,
Ireland.
Pay by wire transfer:
Please transfer funds to:
Account number
833 130 83
Sort code
98-53-30
Swift code
ULSBIE2D
IBAN number
IE78ULSB98533083313083
Bank Address
Ulster Bank,
27-35 Main Street,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
http://www.researchandmarkets.com/info/terms.asp
Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353-1-481-1716 or +353-1-653-1571 - From Rest of World